K913-0626 Screening compound: 2-[5-methyl-6-(1,2,3,4-tetrahydroquinoline-1-carbonyl)thieno[2,3-d]pyrimidin-4-yl]-1,2,3,4-tetrahydroisoquinoline

K913-0626 Screening compound: 2-[5-methyl-6-(1,2,3,4-tetrahydroquinoline-1-carbonyl)thieno[2,3-d]pyrimidin-4-yl]-1,2,3,4-tetrahydroisoquinoline
K913-0626 Screening compound: 2-[5-methyl-6-(1,2,3,4-tetrahydroquinoline-1-carbonyl)thieno[2,3-d]pyrimidin-4-yl]-1,2,3,4-tetrahydroisoquinoline alternative view

Chemical Structure Depiction of ChemDiv screening compound K913-0626
2-[5-methyl-6-(1,2,3,4-tetrahydroquinoline-1-carbonyl)thieno[2,3-d]pyrimidin-4-yl]-1,2,3,4-tetrahydroisoquinoline

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K913-0626

Molecular Formula

C26H24N4OS (C26 H24 N4 OS)

Compound Name

2-[5-methyl-6-(1,2,3,4-tetrahydroquinoline-1-carbonyl)thieno[2,3-d]pyrimidin-4-yl]-1,2,3,4-tetrahydroisoquinoline

IUPAC name

2-[5-methyl-6-(1234-tetrahydroquinoline-1-carbonyl)thieno[23-d]pyrimidin-4-yl]-1234-tetrahydroisoquinoline

SMILES

Cc1c(C(N(CCC2)c3c2cccc3)=O)sc2ncnc(N(CC3)Cc4c3cccc4)c12

InChI

InChI=1S/C26H24N4OS/c1-17-22-24(29-14-12-18-7-2-3-9-20(18)15-29)27-16-28-25(22)32-23(17)26(31)30-13-6-10-19-8-4-5-11-21(19)30/h2-5,7-9,11,16H,6,10,12-15H2,1H3

InChI Key

SAQNPKNBFDRDGD-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15114167

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

440.57

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

5.880

Distribution Coefficient, logD

5.874

Water Solubility, LogSw

-5.71

Polar Surface Area

39.513

Acid Dissociation Constant (pKa)

18.78

Base Dissociation Constant (pKb)

5.51

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

26.90

K913-0626 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS Targets (44014 compounds)

GPCR Targeted Library (31838 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Nervous system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with K913-0626 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K913-0626?
Check Price and Availability of K913-0626, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K913-0626 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K913-0626
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K913-0626
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K913-0626 available by request